Meet man who owns 71 hospitals, 5000 pharmacies, goes office daily at age of 92, net worth is Rs 26560 crore, his name is...
New Delhi: Age 92 years, working 9 hours a day and a business worth thousands of crores. You might not believe it at first but this is the reality. At this age when most people become incapable of moving around, Dr. Prathap C. Reddy, the founder of Apollo Hospitals, goes to his office every day at the age of 92. The hard work and vision of the founder of the largest hospital network in the country have transformed the entire scenario of health services in India. Dr. Reddy works in the office every day from 10 AM to 5 PM.
Even today, Dr. Reddy's energy and dedication to work are no less than that of a young person. He says that health services are his passion and he wants to continuously improve them. Dr. Reddy started the country's first corporate hospital, Apollo Hospitals, in 1983. At that time, there was a lack of good healthcare facilities in the country, and people used to go abroad for treatment.
Dr. Reddy was determined to provide global-level medical facilities within the country. His vision has forever changed the healthcare services in the country. Born in Chennai, Dr. Reddy studied MBBS at Stanley Medical College and received training as a cardiologist in the United States. A letter from his father in the 1970s inspired him to return to India. In 1979, the death of a patient due to inadequate facilities shattered him so much that he decided to start Apollo Hospitals afterward. He also vowed that no one would die due to lack of treatment again.
Today, Apollo Hospitals is not just a hospital but a large healthcare empire. Apollo has 71 hospitals, over 5000 pharmacy outlets, 291 primary care clinics, a diagnostic network, and a digital health platform across the country. Quality healthcare services are being provided at every corner of the country by this group. The group is continuously expanding these facilities. The market cap of Apollo Hospitals is currently over 70,000 crores.
The Reddy family holds a 29.3% stake in it. According to Forbes, Dr. Reddy's total wealth is Rs 26,560 crores. Despite such wealth, he lives a very simple life. Dr. Reddy believes that success makes us humble and inspires us to work more for the country. In an interview with Business Today, he said, 'We should use our success to make the country better.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Apollo Hospital Share Price Live Updates: Closing Price Update for Apollo Hospital
23 Jun 2025 | 08:40:34 AM IST Stay up-to-date with the Apollo Hospital Stock Liveblog, your trusted source for real-time updates and thorough analysis of a prominent stock. Explore the latest details on Apollo Hospital, including: Last traded price 7063.5, Market capitalization: 101562.29, Volume: 378436, Price-to-earnings ratio 70.24, Earnings per share 100.56. Get a comprehensive understanding of Apollo Hospital with our coverage of both fundamental and technical indicators. Stay informed about breaking news that can have a significant impact on Apollo Hospital's performance. Our expert opinions and recommendations empower you to make well-informed investment choices. Trust the Apollo Hospital Stock Liveblog to keep you informed and equipped in the dynamic market landscape. The data points are updated as on 08:40:33 AM IST, 23 Jun 2025 Show more
New Indian Express
11 hours ago
- New Indian Express
‘We plan to add 1,700 beds by FY27; 57% beds likely in tier 2/3 cities'
Kochi- and Dubai-based Aster DM Healthcare, founded by Dr Azad Moopen in 1987 with a single clinic in Dubai, expects to complete the takeover of the Blackstone and TPG-backed Quality Care Hospital by the fourth quarter of this fiscal. The takeover will result in the third largest hospital chain Aster Quality Care, after Apollo and Fortis, with 38 hospitals across four brands -- Aster DM, Care Hospitals, KIMS Health and Evercare -- offering over 10,150 beds spread across 27 locations. Aster Quality Care is now jointly controlled by the Moopen family holding 24% and Blackstone owning 30.7%. In an interaction with Benn Kochuveedan of TNIE, Dr Azad Moopen shares his plans and expectations from the largest deal that his group has done. Excerpts: When do you see the merger of Quality Care Hospital getting completed? What are the targets in terms of revenue, profit expansion etc? The merger brings together four leading healthcare brands — Aster DM, Care Hospitals, KIMS Health, and Evercare — forming one of the largest hospital chains with 38 hospitals and over 10,150 beds across 27 cities. Financially, the merger strengthens the balance sheet and cash flow, enabling accelerated expansion plans. We aim to increase bed capacity to around 13,300 beds by FY27, further expanding our reach into tier 2 and 3 cities, providing a platform for sustained growth in the future. The merger is expected to be concluded by Q4FY26, with benefits expected to start flowing in from early FY27. What are the synergies you see from the merger? The merger unlocks significant synergies that will drive growth, operational efficiencies, and enhanced patient care across the combined network. Integrating our extensive hospital portfolios will allow the new entity to benefit from economies of scale by negotiating better terms with suppliers, reducing costs, and streamlining inventory management that will lower operational expenses and improve margins. What is the capex plan for fiscal 2026, especially in light of the merger-driven expansion? How many more hospitals and beds to come up this fiscal? We plan to add 1,700 beds by FY27, taking the total bed tally in India to over 6,800 through the organic route and will further look for expansion through the inorganic route. Our overall capital allocation for expansion across the domestic market is Rs 1,400 crore, of which we have already spent around Rs 350-400 crore. You have announced a Rs 850-crore investment in Kerala. What is the strategic thinking behind focusing so much on Kerala, which is often seen as a relatively mature market? Kerala is now poised for a significant transformation with a planned investment of Rs 850 crore over the next three years. This expansion will be anchored by two major greenfield projects: Aster Capital Trivandrum, a 454-bed tertiary care facility, and Aster MIMS Kasaragod, a 264-bed multispecialty hospital. In addition, our flagship hospital, Aster Medcity in Kochi, is undergoing a substantial upgrade. By FY27, our total bed capacity in Kerala is expected to reach 3,453, marking a milestone in our journey of delivering quality healthcare and driving sustainable growth. Affordable healthcare remains a chimera for the average citizen. What is Aster doing differently on this front? To balance affordability and sustainability, we centralise complex procedures in larger hospitals, while smaller units focus on primary/secondary care. By FY27, as much as 57% of our planned bed additions will be in tier 2/3 cities, reinforcing our commitment to these regions. Technology is key to bridging gaps, with telemedicine set to grow at 20.7% annually till FY30, reaching $15.1 billion. Our digital health arm is expanding tele-ICU, teleradiology, AI-driven diagnostics, IoT monitoring, and EMR platforms to enhance accessibility, affordability, and quality care nationwide. What are the digital initiatives of the group? Some of our technology-driven, patient-friendly initiatives include the introduction of the Aster Health app that offers appointment bookings, e-pharmacy, and access to digital health records. We have come up with AI-powered diagnostic solutions, including the Carpal Tunnel Syndrome detection tool in collaboration with the Indian Institute of Science. We are also expanding the home healthcare services under Aster@Home, providing in-home consultations, diagnostics, and physiotherapy, catering to India's growing elderly and chronic care populations.
Hans India
12 hours ago
- Hans India
TN health dept to set up 750-bed multi-specialty hospital in Chennai: Minister
Tamil Nadu Health Minister Ma Subramanian said on Sunday that the state government is set to establish a state-of-the-art 750-bed multispecialty paediatric hospital at the King Institute of Preventive Medicine and Research campus in Guindy. The new facility will be developed on six acres of land and will be attached to a postgraduate and super-specialty paediatric institute under the Tamil Nadu Dr. MGR Medical University. Once completed, it will become the third major healthcare institution on the Guindy campus, following the Kalaignar Centenary Super-speciality Hospital and the National Institute of Ageing. The state government has allocated Rs 487.66 crore for the project, which will include a seven-storey hospital complex covering 3.15 lakh square feet. In addition to the main hospital building, the project will feature hostels for doctors, nurses, medical students, and professors, along with advanced medical equipment and infrastructure. "This is the highest allocation made for any hospital project in Tamil Nadu till now," said Minister Subramanian during his visit to the site, accompanied by senior health officials, including Health Secretary P. Senthilkumar. Chief Minister M.K. Stalin has given his approval for the project, and tenders will be floated shortly. The construction of the new hospital is expected to commence by September this year. The institute will be fully funded and operated by the Tamil Nadu Dr. MGR Medical University. The upcoming paediatric hospital will be equipped with 100 intensive care unit (ICU) beds, pay wards, shared wards, and suite rooms. According to University Vice-Chancellor K. Narayanasamy, the hospital will house 20 departments, including 14 unique specialties. These will include general medicine, critical care, surgery, gastroenterology, orthopaedics, neurology, nephrology, pulmonology, cardiology, urology, hemato-oncology, neurosurgery, plastic surgery, and an organ transplant unit. Narayanasamy added that the institute will offer postgraduate super-specialty courses in paediatrics after its establishment. It aims to function as a centre of excellence, particularly for rare paediatric diseases, and will focus on bridging the gap between academic training and real-world healthcare delivery, he said. The new paediatric institute is also expected to bolster the university's academic standing and aid in participation in the National Institutional Ranking Framework (NIRF), enhancing Tamil Nadu's reputation in medical education and research.
